Co-administering Melatonin With an Estradiol-Progesterone Menopausal Hormone Therapy Represses Mammary Cancer Development in a Mouse Model of HER2-Positive Breast Cancer-Reference-Cited by-同舟云学术

Co-administering Melatonin With an Estradiol-Progesterone Menopausal Hormone Therapy Represses Mammary Cancer Development in a Mouse Model of HER2-Positive Breast Cancer

Published:2019-07-09 Issue: Volume:9 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Dodda Balasunder R.,Bondi Corry D.,Hasan Mahmud,Clafshenkel William P.,Gallagher Katie M.,Kotlarczyk Mary P.,Sethi Shalini,Buszko Ethan,Latimer Jean J.,Cline J. Mark,Witt-Enderby Paula A.,Davis Vicki L.

Funder

Susan G. Komen

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference145 articles.

1. Melatonin: an inhibitor of breast cancer;Hill;Endocr Relat Cancer.,2015

2. Melatonin for the prevention and treatment of cancer;Li;Oncotarget.,2017

3. Melatonin, a full service anti-cancer agent: inhibition of initiation, progression and metastasis;Reiter;Int J Mol Sci.,2017

4. Melatonin and cancer hallmarks;Talib;Molecules,2018

5. Mechanisms underlying tumor suppressive properties of melatonin;Bondy;Int J Mol Sci.,2018

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring Melatonin’s Multifaceted Role in Polycystic Ovary Syndrome Management: A Comprehensive Review;Cureus;2023-11-16

2. Modern possibilities for the correction of menopausal symptoms in patients with breast cancer, depending on the molecular biological characteristics of the tumor (literature review);Tumors of female reproductive system;2023-10-27

3. Illuminating the Tug-of-War between Estrogen and Melatonin in Estrogen Receptor Positive Breast Cancer Progression;2023

4. Melatonin Alleviates Ovariectomy-Induced Cardiovascular Inflammation in Sedentary or Exercised Rats by Upregulating SIRT1;Inflammation;2022-06-04

5. Molecular mechanism of inhibitory effects of melatonin on prostate cancer cell proliferation, migration and invasion;PLOS ONE;2022-01-21